July 2023 - BioMedWire (BMW)

MondayJul 31, 2023 11:39 am

Researchers Trace Glioma Brain Tumor Origins to Epigenome

Estimates from the American Cancer Society show that doctors will diagnose around 24,000 malignant spinal cord or brain tumors this year, with an estimated 18,990 people losing their lives to the condition. Gliomas are a class of tumors that grow on the brain or spinal cord, applying pressure onto crucial parts of the brain and causing symptoms such as headaches, memory loss, cognitive decline, irritability, personality changes, vision problems, seizures and speech difficulties. Gliomas can be quite hard to treat because they tend to grow quickly into the spinal cord or brain, making their removal via surgery without damaging any…

FridayJul 28, 2023 11:11 am

Review Shows AI Could Be Pivotal in Infectious Disease Prevention

The worst of the coronavirus pandemic may be in the past, but it showed just how badly a fast-spreading infectious disease could affect the world. Most countries were woefully unprepared to deal with a medical event of that magnitude, and for the most part, the world still isn’t equipped to deal with such a pandemic. Millions of lives were lost worldwide during the pandemic, and to this day thousands of people across the world are still dealing with long Covid symptoms. Researchers recently discussed the possibility of using machine learning and artificial intelligence to prevent future disease outbreaks and pandemics.…

FridayJul 28, 2023 9:45 am

Genprex Inc. (NASDAQ: GNPX) Secures Exclusivity for REQORSA(R)-Keytruda(R) Drug Combination in China with Chinese Patent

Genprex recently received a patent in China covering the use of its drug candidate REQORSA(R) immunogene therapy in combination with PD-1 antibodies, such as Keytruda(R), to treat cancers The REQORSA-Keytruda drug combination is the subject of Genprex’s ongoing Acclaim-2 clinical trial, which targets patients with advanced, metastatic non-small cell lung cancer whose disease progressed after treatment with Keytruda The company has received patent protection for the REQORSA-Keytruda drug combination in the U.S., Japan, Australia, Russia, Mexico, and China, meaning the company has secured exclusivity in many of the largest markets The granted patents, three Fast Track Designations, and positive preclinical…

ThursdayJul 27, 2023 1:07 pm

How to Leverage Relationship Marketing to Boost eCommerce, Onsite Sales

The past three decades have seen ecommerce rise from a plucky new upstart in an already established business ecosystem to one of if not the most dominant form of commerce on the globe. Companies such as Amazon revolutionized trade in a major way and allowed companies to significantly spread their reach and serve more customers than they could have previously dreamed of before. With many businesses having either merchant websites or a social media presence to help them attract and retain more customers when the pandemic hit, switching to contactless purchases and home deliveries was relatively easy. After over three…

WednesdayJul 26, 2023 12:12 pm

Data Shows Stress Could Trigger Hair Loss

Around 25% of men and 12% of women will suffer some degree of hair loss by age 30. By age 50, half of men and 25% of women can expect to experience some hair loss. Although both men and women lose between 50 to 100 hairs every day, people with hair loss don’t replace this hair as fast as they lose it. The condition affects more men than women and is often associated with increasing age, genetics, and changes in testosterone levels. Recent data now indicates that excessive hair shedding or telogen effluvium may be caused by stress as well.…

WednesdayJul 26, 2023 9:45 am

M&A Activity, Booming Sales of Anti-IL-17 Drugs Suggest Strong Upside Potential for BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)

BiondVax, a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, was featured in a recent analyst report reiterating a Buy recommendation and a $70 target price The report discussed Eli Lilly’s announcement of a definitive agreement to acquire DICE Therapeutics for approximately $2.4 billion as evidence of the potential value of BiondVax in this segment of the therapeutics market DICE Therapeutics is currently evaluating its lead drug candidate, DC-806, an oral IL-17 inhibitor, in a Phase II trial, with early-stage results from the Phase I study showing a near-44% reduction in Psoriasis Area and Severity Index The…

TuesdayJul 25, 2023 11:57 am

Clinical Trial Testing Modified Viruses as Brain Cancer Treatment Begins

Researchers from Henry Ford Health’s Hermelin Brain Tumor Center have begun working on a brain cancer treatment that would use modified viruses to fight cancer cells. Hermelin Brain Tumor Center scientists are currently in the midst of a phase 1 clinical trial for a cutting-edge brain cancer treatment that uses a virus modified to destroy tumor tissue in conjunction with fractionated stereotactic radiosurgery. Brain cancers tend to be the most challenging type of cancer to treat. Their proximity to critical brain regions makes them difficult to remove via surgery because it can damage critical nerves, infect the meninges (tissue that…

MondayJul 24, 2023 1:11 pm

Psoriasis Could Be Behind Frequent Fatigue

Psoriasis is a topical condition that causes dry, scaly and itchy patches to develop on the skin around the scalp, trunk, elbows and knees. The condition is chronic and is typically managed using medication to alleviate symptoms, coping strategies and different lifestyle habits to minimize the number of triggers in your life. Even though psoriasis typically acts on the skin, with its symptoms generally affecting different areas of the skin, studies have found that psoriasis may also cause exhaustion. Exhaustion is something we all experience every day. It is a normal part of the human experience that is essentially the…

FridayJul 21, 2023 12:55 pm

2023 Prime Day Sets eCommerce Record

Online retailers on Amazon reported record sales numbers during the recent Prime Day summer sales event, selling more than $12.7 billion worth of product in two days and setting an eCommerce record. Held every year, the summer sale is a members-only event that grants customers exclusive discounts on thousands of different products across nearly every category on the platform. Amazon-only products such as Echo smart speakers, Kindles, Fire Tablets and Fire TV Sticks offered the highest discounts, and even subscription services such as Amazon Music Unlimited were on sale. The event ran from July 11 to 12, 2023, and offered…

FridayJul 21, 2023 9:00 am

National GBM Awareness Events Underscore Significance of Clinical Trial Progress for CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)

National awareness of glioblastoma tumors (“GBM”) sustained by Congressional leaders aim to improve efforts to treat brain cancers and ultimately improve patient survival GBM is a widely occurring, aggressive and effectively incurable brain cancer that few patients survive beyond three years U.S.-based drug developer CNS Pharmaceuticals is in the midst of a global potentially pivotal clinical trial for its lead pharmaceutical candidate, Berubicin, which it aims to show improves on standard of care chemotherapy agent Lomustine’s approach to treating GBM Berubicin is a novel anthracycline that is practically unique in its ability to cross the blood-brain barrier to directly target…